Literature DB >> 1962841

Tandem DNA-bound cAMP-CRP complexes are required for transcriptional repression of the deoP2 promoter by the CytR repressor in Escherichia coli.

L Søgaard-Andersen1, N E Møllegaard, S R Douthwaite, P Valentin-Hansen.   

Abstract

We have studied the deoP2 promoter in Escherichia coli to define features important for its interaction with the CytR repressor. As is characteristic for CytR-regulated promoters, deoP2 encodes tandem binding sites for the activating complex cAMP-CRP. One of these sites, CRP-1, overlaps the -35 region, and is sufficient for activation; the second site, CRP-2, centred around -93, is indispensable for repression. Here we demonstrate, by means of in vivo titration, that CytR interaction with deoP2 depends not only on CRP-2, but also on CRP-1 and the length and possibly the sequence separating these two sites. Also, point mutations in either CRP site reduce or abolish CytR titration; however, no co-operativity is observed in the interaction of CytR with the two CRP binding sites. Furthermore, the reduction in CytR titration parallels the reduction in binding of cAMP-CRP to the mutated CRP sites in vitro. These observations are not easily explained by current models for the action of prokaryotic repressors; instead we favour a model in which the interaction of CytR with deoP2 depends on the presence of tandem DNA-bound cAMP-CRP complexes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1962841

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  12 in total

1.  Repression of deoP2 in Escherichia coli by CytR: conversion of a transcription activator into a repressor.

Authors:  M Shin; S Kang; S J Hyun; N Fujita; A Ishihama; P Valentin-Hansen; H E Choy
Journal:  EMBO J       Date:  2001-10-01       Impact factor: 11.598

Review 2.  Cyclic AMP in prokaryotes.

Authors:  J L Botsford; J G Harman
Journal:  Microbiol Rev       Date:  1992-03

3.  Restored DNA-binding of the cAMP-CRP activator complex reestablishes negative regulation by the CytR repressor in the deoP2 promoter in Escherichia coli.

Authors:  L Søgaard-Andersen; P Valentin-Hansen
Journal:  Mol Gen Genet       Date:  1991-12

4.  Single amino acid substitutions in the cAMP receptor protein specifically abolish regulation by the CytR repressor in Escherichia coli.

Authors:  L Søgaard-Andersen; A S Mironov; H Pedersen; V V Sukhodelets; P Valentin-Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

Review 5.  Control site location and transcriptional regulation in Escherichia coli.

Authors:  J Collado-Vides; B Magasanik; J D Gralla
Journal:  Microbiol Rev       Date:  1991-09

6.  Negative regulation of IS2 transposition by the cyclic AMP (cAMP)-cAMP receptor protein complex.

Authors:  S T Hu; H C Wang; G S Lei; S H Wang
Journal:  J Bacteriol       Date:  1998-05       Impact factor: 3.490

7.  Identification of the nucleotide sequence recognized by the cAMP-CRP dependent CytR repressor protein in the deoP2 promoter in E. coli.

Authors:  P B Rasmussen; L Søgaard-Andersen; P Valentin-Hansen
Journal:  Nucleic Acids Res       Date:  1993-02-25       Impact factor: 16.971

8.  Protein-induced fit: the CRP activator protein changes sequence-specific DNA recognition by the CytR repressor, a highly flexible LacI member.

Authors:  H Pedersen; P Valentin-Hansen
Journal:  EMBO J       Date:  1997-04-15       Impact factor: 11.598

9.  Mutations that alter the ability of the Escherichia coli cyclic AMP receptor protein to activate transcription.

Authors:  A Bell; K Gaston; R Williams; K Chapman; A Kolb; H Buc; S Minchin; J Williams; S Busby
Journal:  Nucleic Acids Res       Date:  1990-12-25       Impact factor: 16.971

10.  The cyclic AMP (cAMP)-cAMP receptor protein complex functions both as an activator and as a corepressor at the tsx-p2 promoter of Escherichia coli K-12.

Authors:  P Gerlach; L Søgaard-Andersen; H Pedersen; J Martinussen; P Valentin-Hansen; E Bremer
Journal:  J Bacteriol       Date:  1991-09       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.